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Abstract
Dopamine (phasic release) is implicated in conditioned responses. Imaging studies in cocaine abusers show decreases in
striatal dopamine levels, which we hypothesize may enhance conditioned responses since tonic dopamine levels modulate
phasic dopamine release. To test this we assessed the effects of increasing tonic dopamine levels (using oral
methylphenidate) on brain activation induced by cocaine-cues in cocaine abusers. Brain metabolism (marker of brain
function) was measured with PET and
18FDG in 24 active cocaine abusers tested four times; twice watching a Neutral video
(nature scenes) and twice watching a Cocaine-cues video; each video was preceded once by placebo and once by
methylphenidate (20 mg). The Cocaine-cues video increased craving to the same extent with placebo (68%) and with
methylphenidate (64%). In contrast, SPM analysis of metabolic images revealed that differences between Neutral versus
Cocaine-cues conditions were greater with placebo than methylphenidate; whereas with placebo the Cocaine-cues
decreased metabolism (p,0.005) in left limbic regions (insula, orbitofrontal, accumbens) and right parahippocampus, with
methylphenidate it only decreased in auditory and visual regions, which also occurred with placebo. Decreases in
metabolism in these regions were not associated with craving; in contrast the voxel-wise SPM analysis identified significant
correlations with craving in anterior orbitofrontal cortex (p,0.005), amygdala, striatum and middle insula (p,0.05). This
suggests that methylphenidate’s attenuation of brain reactivity to Cocaine-cues is distinct from that involved in craving.
Cocaine-cues decreased metabolism in limbic regions (reflects activity over 30 minutes), which contrasts with activations
reported by fMRI studies (reflects activity over 2–5 minutes) that may reflect long-lasting limbic inhibition following
activation. Studies to evaluate the clinical significance of methylphenidate’s blunting of cue-induced limbic inhibition may
help identify potential benefits of this medication in cocaine addiction.
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Introduction
Dopamine (DA), a neurotransmitter that processes reward and
prediction of reward [1,2] is involved with the reinforcing effects of
drugs of abuse [3,4] and with responses to drug conditioned cues
[5,6,7]. Specifically, fast and large DA increases, as those achieved
with phasic DA cell firing (15–30 Hz), are implicated in both drug
reward [8,9] and conditioned cues [10,11]. Indeed imaging studies
have shown that the fast DA increases achieved with intravenous
administration of methylphenidate (stimulant drug that increases
DA by blocking DA transporters) are associated with its
reinforcing effects [12] whereas similar but slower DA increases
after oral administration of methylphenidate (MP) are not
perceived as reinforcing [13]. Similarly the fast DA increases as
triggered by conditioned cues [10,11] are linked with craving
responses in cocaine abusers [14,15] whereas a similar magnitude
of DA increases but achieved slowly (as induced by oral
administration of MP) do not elicit craving [16]. Tonic DA cell
firing (2–10 Hz), which results in stable and lower DA levels,
appears to modulate such phasic DA cell firing via activation of
inhibitory DA autoreceptors [17]. It has been hypothesized that
repeated drug use results in increases in tonic DA levels that
dampen phasic DA responses driving compulsive drug adminis-
tration as an attempt to overcome the attenuated phasic DA
signaling [18]. However, imaging studies performed in cocaine
abusers studied during early or protracted detoxification have
shown evidence of decreased striatal DA activity [19], including
decreases in non-stimulated DA release [20], which suggest a
decrease in tonic DA cell firing. Since low tonic DA levels would
enhance phasic DA cell firing in response to conditioned-cues [21]
we reasoned that increasing tonic DA levels in cocaine abusers
would attenuate phasic DA responses to conditioned-cues and
blunt the downstream activation of regions and circuits associated
with these responses.
To test this hypothesis we assessed the effects of raising tonic DA
levels by giving a low dose of oral MP (20 mg) [22] on the regional
brain metabolic activation induced by cocaine-cues in cocaine
abusers. We used Positron Emission Tomography (PET) and 2-
deoxy-2[
18F]fluoro-D-glucose (
18FDG) to measure brain glucose
metabolism (marker of brain function) [23] in 24 active cocaine
abusers. Subjects were tested on four different days each under a
different condition; twice while watching a neutral video (nature
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twice while watching a video of cocaine-cues (repeating scenes of
people taking cocaine), once with placebo and once with MP. The
cocaine-cues video used was one we had previously shown to
induce significant increases in striatal DA, which was an effect
associated with increases in drug craving in cocaine abusers [14].
We chose a dose of MP (20 mg oral), which we had previously
shown induced significant increases in striatal DA in cocaine
abusers but that did not elicit drug craving nor was it perceived as
reinforcing [16]. Cocaine craving was measured using a brief
version of the Cocaine Craving Questionnaire (CCQ) that
evaluates current cocaine craving [24].
We hypothesized that MP by increasing tonic DA levels would
dampen phasic DA firing triggered by conditioned cues and thus
the activation pattern elicited by cocaine-cues would be attenuated
when MP was given as compared to when placebo was given. We
also hypothesized that this would be associated with reduced
craving.
Results
Concentration of MP in plasma
Plasma MP levels did not differ between conditions and
corresponded for the Neutral and the Cocaine-cues conditions
respectively, at 30 minutes post administration to: 3.063 and
3.363 ng/ml; at 60 minutes to: 5.763 and 5.664 ng/ml; at 90
minutes to: 6.462 and 6.163 ng/ml; and at 120 minutes to:
6.162 and 5.762 ng/ml. Plasma MP levels were not significantly
correlated with cardiovascular, behavioral or brain metabolic
measures.
Cardiovascular measures
Heart rate and systolic blood pressure (BP) increased signifi-
cantly for all conditions (pre vs post) (Table 1). Comparisons
between conditions were significant for heart rate (Repeated
ANOVA F=7, df 3, 69, p,0.0005) and systolic BP (Repeated
ANOVA F=4, df 3, 69, p,0.02) but not for diastolic BP (Table 1).
For heart rate the comparisons between Neutral and Cocaine-cues
were significant (P,0.05); the comparisons between Placebo and
MP were significant (p,0.01) and the interaction (Drug by Video)
did not reach significance (p,0.08). For systolic BP the
comparisons between Neutral and Cocaine-cues were significant
(p,0.01), the comparisons between Placebo and MP were
significant (p,0.05) and the interaction (Drug by Video) was
significant (p,0.02).
Craving measures
The craving measures (CCQ and self-reports) increased
significantly with the Cocaine-cues exposure for both conditions
(placebo or MP). For CCQ repeated ANOVA (measures prior to
drug exposure, measures prior to video exposure, and measures
post video exposure) differed significantly for the Cocaine-cues
when given with PL (p,0.002) and when given with MP
(p,0.003) but did not differ for the Neutral video conditions (PL
or MP) (Table 2). The self-reports of craving were significantly
higher for the Cocaine-cues video condition both for PL (p,0.002)
and for MP (p,0.001). The interaction between drug and video
condition was not significant.
Absolute metabolic measures
Whole brain absolute metabolic measures corresponded for
Neutral with PL to 34.965 mmol/100 g/min, for Neutral with
MP to 36.165 mmol/100 g/min, for Cocaine-cues with PL to
35.065 mmol/100 g/min and for Cocaine-cues with MP to
35.965 mmol/100 g/min and the measures did not differ between
conditions. The SPM analysis also showed no differences between
conditions for the absolute metabolic images.
Normalized metabolic measures
SPM comparisons for the normalized metabolic measures
showed significant decreases in relative metabolism for the
Cocaine-cues video when compared with the Neutral-video that
were more extensive with Placebo than with MP. When Placebo
was given decreases were significant in left limbic regions (lateral
orbitofrontal cortex (OFC)/anterior insula (BA 47 and BA 11),
Table 1. Percent change in cardiovascular measures from the baseline state (prior to video and placebo exposures) to measures
averaged during exposure to the videos (post).
Neutral Placebo Cocaine-cues Placebo Neutral MP Cocaine-cues MP ANOVA
Heart Rate 6.5%66 6.0%66 8.2%65 12.7%68* F=7, p,0.0005
Systolic BP 2.5%64 1.8%66 1.4%66 6.6%66*t F=4,p,0.02
Diastolic BP 20.1%65 20.4%66 0.6%66 2.6%67 F=1.5, p,0.21
Measures correspond to mean and SD. ANOVA results correspond to the comparisons of the percent changes across conditions (df 3, 69).
*Connotes significant increase between the MP/Neutral and the MP/Cocaine-cues.
t Significant interaction effect between video and drug condition.
doi:10.1371/journal.pone.0011509.t001
Table 2. Scores on the measures of cocaine craving obtained
with the CCQ and with self-reports of craving for the 4
conditions.
CCQ Pre PL or MP Pre Video End video ANOVA
Neutral PL 29611 27611 27612 F=0.4 p,0.64
Neutral MP 29610 30611 29611 F=1, p,0.36
Cocaine-cues PL 31612 30611 35614 F=5, p,0.008
Cocaine-cues MP 30612 29610 35613 F=7, p,0.002
Self-reports
Neutral PL 2.762 2.3622 . 2 61F = 1 , p ,0.32
Neutral MP 2.762 2.4622 . 7 62 F=0.4, p,0.70
Cocaine-cues PL 2.963 2.5624 . 2 63F = 7 , p ,0.002
Cocaine-cues MP 3.063 2.8624 . 6 63F = 8 , p ,0.001
ANOVA results correspond to the comparisons within conditions (df 2, 46). The
interaction between drug (placebo vs methylphenidate) by video condition
(Neutral vs Cocaine-cues) was not significant. PL= placebo, MP =
methylphenidate.
doi:10.1371/journal.pone.0011509.t002
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(BA 36 and 37), and in auditory (left BA 22 and left and right BA
42) and visual areas (left lingual gyrus) (Figure 1 and Table 3 for
location of areas). In contrast when MP was given the only
significant differences were in the right visual (inferior BA 18) and
right auditory (BA 42) regions (Figure 1, Table 3 shows location of
areas).
To control for potential findings driven by the effects of MP in
the Neutral video we also compared the effects of MP with those of
Placebo. The SPM analysis revealed significant decreases for both
video conditions in precentral gyrus (BA 6) and with the Neutral
video additional decreases in posterior cingulate (BA 30), superior
temporal and postcentral gyrus (Figure 2, Table 4).
The SPM analysis of the interaction effect between video and
drug condition showed that the decreases with the Cocaine-cues
were attenuated when MP was given when compared to placebo.
Specifically the decreases when the cocaine-cues were given with
placebo versus when given with MP were significantly greater in
the right and left lingual gyrus, left hippocampal gyrus, left
accumbens/BA 25 region and left lateral OFC (BA 47) (Figure 3,
and Table 5 for location of areas).
Correlations between normalized metabolic changes and
craving
Correlation analysis between the regions where SPM showed
significant differences between the Neutral video and the Cocaine-
cues video and self-reports of craving (delta scores pre vs post video
exposure) were not significant either for the placebo or the MP
conditions.
In contrast the SPM voxel-wise correlation between changes in
metabolism and self-reports of craving identified several regions
where these correlations were significant but the pattern differed for
placebo and for MP (Figure 4). For the placebo condition increases
in craving were associated with decreases in metabolism in left
inferior parietal (BA 40), left precuneus (BA 7), left precentral gyrus
(BA 4/6), left superior frontal gyrus (BA 8/9) and right medial
frontal gyrus (BA 9/44). In contrast the correlations with MP were
associated with increases in left and right metabolism in OFC (BA
11/47) for the significance threshold of p,0.005. Lowering the
threshold at p,0.05 identified additional positive correlations with
striatum, insula and amygdala (Figure S1).
Figure 1. SPM results on the Video comparison (Neutral vs Cocaine-cues video) for the Placebo (PL), for the Methylphenidate (MP)
and for both conditions (PL and MP) done on normalized metabolic images (Cocaine-Cues , Neutral). The Cocaine-cues lowered
glucose metabolism and this effect was attenuated when subjects were given MP. Threshold of significance p,0.005 uncorrected, cluster size .200
voxels.
doi:10.1371/journal.pone.0011509.g001
Table 3. SPM results for the comparison between the
Cocaine-cues and the Neutral videos (Cocaine-cues , Neutral)
when given with placebo and when given with
methylphenidate (p,0.005 uncorrected, cluster size .200
voxels).
Cocaine-cues vs Neutral
Placebo
Cluster size
(# voxels) T and p x, y, z
L Lingual gyrus 1131 3.86 p,0.001 216 268 26
L Posterior insula 1986 3.84 p,0.001 240 222 24
L BA 47/11-anterior insula 614 4.42 p,0.001 226 26 214
R Parahippocampal 1183 4.20 p,0.001 24 246 210
L NAc 486 3.65 p,0.001 221 4210
R BA 41/42 223 3.54 p,0.001 46 222 10
Cocaine-cues vs Neutral
Methylphenidate
R Lingual gyrus 790 3.61 p,0.001 14 280 210
R BA 41/42 687 3.25 p,0.001 50 220 10
Table shows, cluster size, T value of the comparison, significance (p) and
location of coordinates (in mm) on Montreal Neurological Institute (MNI)
coordinates (x,y,z). L = left, R = right.
doi:10.1371/journal.pone.0011509.t003
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Neither order of the conditions (first, second, third or fourth)
nor age had a significant effect. However, covarying for gender
showed a significant effect (Figure 5). Females showed a greater
reactivity to cues than males.
Discussion
Here we show in cocaine abusers exposed to Cocaine-cues an
unexpected decrease in metabolic activity in limbic brain regions
(neutral . cocaine cues) and a blunting of these regional brain
responses to Cocaine-cues when oral MP was administered but
showed no effect on the subjective experience of craving. Indeed,
the cocaine-cues increased craving (self-reports and CCQ) to the
same extent with placebo as with MP. This dissociation would
suggest that the regions that showed a Cue by Drug interaction
effect (regions where responses to the Cocaine-cues were
attenuated by MP), are not related to the subjective perception
of craving. Indeed the lack of a correlation between the metabolic
changes in these regions and the craving responses support this.
When compared with the neutral video, the cocaine-cues video
did not change whole brain absolute glucose metabolism, which
indicates that when already watching a video the inclusion of
cocaine-cues did not further affect the overall glucose utilization by
the brain. This contrasts with a prior study in which we reported a
10% increase in whole brain metabolism upon exposure to the
same cocaine-cues video but when compared with a baseline
condition (subjects resting with their eyes open with no visual or
auditory stimulation) [25], which highlights the sensitivity of the
activation patterns detected by imaging studies to the comparison
state.
In contrast to the lack of an effect on absolute metabolic
measures, normalization of metabolism by whole brain, revealed
relative decreases in several brain regions with exposure to the
cocaine-cues video as compared to the neutral video. These
differences were significantly larger when placebo than when MP
was given. Specifically during the cocaine-cues video when given
with placebo there were relative decreases in limbic regions that
included left lateral OFC, left anterior and posterior insula and left
nucleus accumbens (NAc), and in the auditory (left BA 22 and left
Figure 2. SPM results on the Drug comparison (Placebo vs MP) for the Neutral Video, for the Cocaine-Cues Video and for both
conditions (Neutral and Cocaine-Cues) done on normalized metabolic images (MP , PL). MP decreased metabolism in superior parietal
regions. Threshold of significance p,0.01 uncorrected, cluster size .200 voxels.
doi:10.1371/journal.pone.0011509.g002
Table 4. SPM results for the comparison between Methylphenidate (MP) and Placebo (MP , Placebo) for the Neutral and the
Cocaine-cues conditions (p,0.01 uncorrected, cluster size .200 voxels).
MP vs Placebo Neutral Cluster size (# voxels) Z-score p values x, y, z
Posterior Cingulate BA 30 1142 3.9 p,.001 8, 252, 8
Superior Temporal BA 42 503 3.9 p, 001 266, 222, 10
Uncus BA 28 758 3.4 p,.002 30, 4, 238
Precentral gyrus BA 6 282 3.3 P,.002 262, 4, 24
Postcentral gyrus BA 3 145 3.2 p,.002 228, 216, 48
MP vs Placebo Cocaine-cues
Precentral gyrus BA 6 175 3.1 p,.002 60, 2, 24
Table shows, the regions, cluster size, T value of the comparison, significance (p) and location of coordinates (in mm) on Montreal Neurological Institute (MNI)
coordinates (x,y,z). L = left, R = right.
doi:10.1371/journal.pone.0011509.t004
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when MP was given the only significant differences were decreases
in right visual (inferior BA 18) and right auditory (BA 42) regions
but no differences in limbic areas.
Thus, the cocaine-cues video when compared with a neutral
video led to a relative decrease in activity of limbic brain regions
when given with placebo. This is consistent with preclinical studies
showing that exposure to cocaine-cues in chronically treated rats
decreased glucose metabolism in limbic regions [26]. However, it
differs from prior imaging studies that have shown activation of
limbic regions with exposure to cocaine-cues. Specifically fMRI
studies with exposure to either a script constructed to evoke
cocaine craving or a video of cocaine-cues have shown BOLD
signal increases in insular cortex as compared to a neutral script or
a neutral video [27,28]. PET studies using videos to evoke craving
have also reported cerebral blood flow (CBF) increases in
amygdala and anterior cingulate though decreases in striatum
[29] whereas others using scripts reported CBF increases in left
insula, NAc and amygdala [30], and studies using recall of cocaine
imagery supplemented with tactile and visual stimulation with
cocaine paraphernalia reported increases in glucose metabolism in
left insula and OFC when compared with recall of family
genealogy [31]. Moreover, fMRI studies during cocaine intoxica-
tion reported that BOLD signal increases in NAc and amygdala
correlated with craving [32] and PET studies during intravenous
MP administration reported that metabolic increases in OFC and
striatum correlated with craving [33]. This would suggest that
activation of limbic regions including NAc, insula and OFC but
not their deactivation may underlie the subjective awareness of
craving. Indeed, while the correlations between craving and the
brain regions deactivated by the Cocaine-cues were not significant,
the voxel-wise correlation analysis identified for the MP condition,
a positive correlation between craving and right and left OFC
(P,0.005), insula, amygdala and striatum (p,0.05 supplemental
Figure 1), which is consistent with prior findings (27–32). In
contrast, with placebo the correlations were negative and included
cortical regions involved with executive control (BA 8, BA 9, BA
44) and regions that are part of the posterior default mode network
or DMN (precuneus and inferior parietal regions). Thus this would
suggest that individuals who experienced the most craving may
show impairment in executive function upon exposure to cocaine-
cues. Indeed there is evidence of disrupted executive function in
cocaine abusers when performing tasks that involved conditioned-
cues (34). Enhanced deactivation (decreased metabolism) of the
DMN, which is deactivated when attending to external stimuli
(35), would be consistent with a greater engagement of the
individual’s attention by the Cocaine-cues video than the Neutral
video.
In interpreting the results from this study it is crucial to
recognize that glucose metabolic measures reflect activity over a
30 minute period and thus the limbic deactivation observed with
the cocaine-cues video could reflect a longer lasting effect from
exposure to conditioned-cues that may have followed an initial
short lasting activation. This is plausible since DA cell firing
decreases after the expectation of a predicted reward (from a
conditioned stimulus) does not occur [36]. In this respect it is of
interest that the only other brain imaging study that measured
change in brain glucose metabolism with exposure to a cocaine-
cues video and that reported increases in prefrontal cortex,
amygdala and cerebellum was done in cocaine abusers who were
told that at the end of the study they would receive a dose of
cocaine [37], which contrasts with our experiment for which
cocaine abusers were not expecting to receive cocaine post-session.
In fact, studies in the nicotine field have shown that expectation of
drug delivery post-session modulates cue-responses [38]. Future
studies are required to assess the behavioral significance of the
metabolic decrements observed with exposure to conditioned-cues
and the consequences of their attenuation by MP. For example,
does the impairment in executive function following exposure to
cocaine-cues [34] improve with MP?
The discrepancies between our findings of decreases in limbic
metabolism and prior imaging studies showing limbic activation
with cues exposures are also likely to reflect the sensitivity of brain
responses to the mechanisms used to elicit craving (and as
importantly the control condition used to compare this) and to the
imaging methods used to measure them (fMRI, PET-CBF, PET-
metabolism). For example, the much higher temporal resolution of
fMRI enables the detection of areas with dynamic patterns of
activation/deactivation as has been reported to occur during
cocaine-induced craving [32]. Similarly the contrast comparison is
also likely to influence the results obtained as discussed above.
The cocaine-cues video when compared with the neutral video
decreased relative activity in somatosensory cortices (visual and
Figure 3. SPM results for the Video (Neutral vs Cocaine-cues) by Drug (Placebo vs MP) interaction (MP , PL). Methylphenidate resulted
in less metabolic changes than the Placebo and there were no regions were the differences were greater for Methylphenidate than for the Placebo
conditions. Threshold of significance p,0.01 uncorrected, cluster size .200 voxels.
doi:10.1371/journal.pone.0011509.g003
Table 5. SPM results for the Video (Neutral vs Cocaine-cues)
by Drug (Placebo vs MP) Interaction (MP , PL).
Region Cluster # voxels T, p x,y,z
R Lingual Gyrus 788 3.95, p,0.0001 10, 250, 6
L Lingual Gyrus L
Hippocampal Gyrus
1082 3.79, p,0.001 212, 272,
210
218, 244,
26
L NAc/BA 25 287 3.29, p,0.002 24,10, 28
L BA 47 407 3.12, p,0.002 226, 24, 212
Table shows the regions, cluster size, T value, significance (p) and location of
coordinates (in mm) on Montreal Neurological Institute (MNI) coordinates
(x,y,z). When given MP the differences between the Neutral vs the Cocaine-cues
video was less than when given placebo. L = left, R = right.
doi:10.1371/journal.pone.0011509.t005
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inferior occipital cortex. Though we do not have an explanation
for these decreases we speculate that this may reflect differences in
the objects and sounds presented by both videos.
In this study we also show that MP decreased metabolic activity
in precentral cortex (BA 6) and posterior cingulate gyrus (BA 30)
for the Neutral condition. Since the posterior cingulate is part of
the DMN that gets deactivated with stimulation [35] this would be
consistent with the interpretation that MP facilitates the
deactivation of the DMN. Indeed, in healthy controls we showed
that MP (20 mg po) attenuated the brain activation responses to a
cognitive task and facilitated the deactivation of the DMN, when
compared with a resting condition [39].
The Cocaine-cues significantly increased heart rate and systolic
BP and the effect was more robust when MP was given than when
placebo was given. This indicates that some of the peripheral
responses to conditioned-cues may be amplified by MP. Indeed
studies with oral MP in cocaine abusers that were given cocaine
showed an enhancement of cocaine’s cardiovascular effects [40].
When covarying for gender we showed a significant gender
interaction effect; females were more reactive to cocaine-cues than
males. This highlights the importance of future studies to
separately investigate the effects of gender in cue-reactivity and
in responses to addiction treatments. In contrast neither age nor
sequence of scans influenced the results.
Here we observed an attenuation of the limbic responses to
conditioned-cues by MP that may be beneficial in decreasing the
negative effects that exposure to conditioned cues may have on
cocaine abusers (i.e., mood, cognitive function, impulsivity).
However clinical trials with MP for the treatment of cocaine
addiction have been inconclusive [41]. Future studies that evaluate
the potential benefits of MP on executive cognitive function
following cocaine-cues exposure may help identify potential
therapeutic benefits of this medication in cocaine addiction.
Study Limitations
A limitation for this study is that changes in brain metabolism,
which average activity over 30 minutes, may lack the temporal
sensitivity to identify the dynamic changes in brain activity elicited
by cue exposures as detected with fMRI. On the other hand the
metabolic method may help identify the longer lasting conse-
quences that follow exposure to conditioned cues.
Another limitation is the use of conscious awareness of craving
as the dependent variable. Indeed it is likely that unconscious
responses to conditioned-cues responses are as important in
triggering drug consumption. This is particularly relevant since
Figure 4. SPM results for the voxel-wise correlation between changes in metabolism and changes in self-reports of cocaine craving
(Neutral - Cocaine-cues) for the Placebo and the Methylphenidate conditions (p,0.005 uncorrected, cluster size .200 voxels). For
Placebo the correlations were negative (decreases in metabolism associated with increases in craving) whereas with Methylphenidate these were
positive (increases in metabolism associated with increases in craving).
doi:10.1371/journal.pone.0011509.g004
Figure 5. SPM results on comparison (Neutral vs Cocaine-cues video) for the Placebo (PL) and the Methylphenidate (MP) conditions
done on normalized metabolic images for the Females (n=8) and the Male subjects (n=16). The threshold of significance was set at
p,0.005 uncorrected, cluster size .200 voxels. Females showed greater decreases to the Cocaine-cues when compared to the Neutral video than
males.
doi:10.1371/journal.pone.0011509.g005
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between interoceptive processes and subjective awareness [42].
Another limitation was that we did not record eye tracking nor did
we require responses during the video exposure that would have
assured us that the subjects were attending to the video. However
the fact that the subject’s heart rate and blood pressure increased
while they watched the cocaine-cues video indicates that the
subjects were attending to the stimuli.
It would have been desirable to include a control group to assess
the specificity of MP effects to conditioned-cues in addicted
individuals.
Finally though we hypothesized that oral MP would blunt the
responses to conditioned cues by increasing DA tone and blunting
phasic DA signals triggered by conditioned cues we can not
determine that this was the mechanism responsible for the
attenuation of the regional brain metabolic changes triggered by
the Cocaine-cues. PET studies to directly measure DA changes
triggered by cues with and without oral MP are necessary to
corroborate this.
Summary
These results document a blunting of regional brain metabolic
responses to cocaine-cues by oral MP but failed to corroborate our
hypothesis that this would be associated with a parallel blunting in
craving. The functional significance of the limbic deactivation
after exposure to conditioned-cues and its blunting by MP merits
further investigation.
Materials and Methods
Subjects
Twenty-four active cocaine abusers (16 M and 8 F; 4266 years
of age; 1362 years of education) who responded to an
advertisement were studied. Subjects fulfilled DSM-IV criteria
for cocaine dependence and were active users for at least the prior
6 months (free-base or crack) with average cocaine use of 3.562
grams/day; 1565 years of abuse and average time of last cocaine
use was 262 days. Exclusion criteria included current or past
psychiatric disease other than cocaine or nicotine dependence (22
subjects were smokers); past or present history of neurological,
cardiovascular or endocrinological disease; history of head trauma
with loss of consciousness greater than 30 minutes; and current
medical illness. Scores for the ‘‘drug’’ domain of the Addiction
Severity Index [43], corresponded to 8.662; and scores for the
Cocaine Selective Severity Assessment Scale [44] corresponded to
2765. Written informed consent was obtained from all subjects.
Behavioral Scales
To assess the subjective experience of craving we used an analog
scale (1–10) for self-reports of ‘‘cocaine craving’’ and the brief
version of the Cocaine Craving Questionnaire (CCQ) [24], which
evaluates current cocaine craving on a seven-point visual analogue
scale. These measures were obtained prior to drug administration
(placebo or MP), prior to video exposure, and 40 minutes after
(post) initiation of the video. Repeated ANOVA was used to
compare differences between neutral and cocaine-cues and to
assess if there was an interaction effect between video and drug
conditions.
Cardiovascular measures
Heart rate and blood pressure were monitored continuously
throughout the procedure from which we computed the measures
obtained 40 minutes prior to the video presentation (Pre) and those
obtained 40 minutes after initiation of the video (Post). For the
statistical comparisons we used the difference between the Pre and
the Post measures and expressed these as percent change from the
Pre measures. Repeated ANOVA was used to compare differences
between neutral and cocaine-cue and to assess if there was an
interaction effect between video (neutral vs cocaine-cures) and
drug (placebo vs MP).
Scans
PET scans were conducted with a whole-body, high-resolution
positron emission tomograph (Siemens/CTI ECAT HR+, with
4.664.664.2 mm NEMA (National Electrical Manufacturers
Association) using
18FDG. Details on the methods for scanning
have been published [45]. Briefly, a 20 minutes emission scan was
started 35 minutes after injection of 4–6 mCi of
18FDG.
Arterialized blood sampling was used to measure
18F in plasma.
All subjects were scanned four different times each on a separate
day under the following randomly ordered conditions (1) oral
placebo while watching a Neutral video; (2) oral placebo while
watching the cocaine-cues video; (3) oral MP (20 mg) while
watching the neutral video; and (4) oral MP (20 mg) while
watching the cocaine cues-video. The order of the 4 scans was
randomly varied so that only two subjects ended up by having the
same sequence of conditions.
Videos were started 15 minutes prior to injection of
18FDG (60
minutes after placebo or MP administration) and were continued
for 25 minutes after
8FDG injection (total of 40 minute exposure to
the video). Figure 6 shows a diagram of the experimental
procedures. The neutral video featured non-repeating segments
Figure 6. Diagram of experimental protocol.
doi:10.1371/journal.pone.0011509.g006
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segments portraying scenes that simulated purchase, preparation,
and smoking of cocaine [14].
Image and data Analysis
The data were analyzed using a general lineal model with the
Statistical Parametric Mapping (SPM) software package [46]. The
SPM analyses were performed on metabolic images that were
normalized to whole brain metabolism, which increases the
sensitivity to regional effects. The images were then spatially
normalized using the Montreal Neurological Institute (MNI)
template provided in SPM2 and subsequently smoothed with a
16 mm isotropic Gaussian kernel. The four relative metabolic
maps corresponding to different conditions (cocaine video, neutral
video, placebo, and MP) for each subject were included in a one-
way (within-subjects) repeated measures ANOVA model in SPM2.
Three variables, session order, age of the subjects and gender were
used as covariates in the analyses. Significance was set at p,0.005
(uncorrected, .100 voxels). Statistical maps were overlaid on an
MRI structural image.
Pearson product moment correlations were performed to assess
the relationship between the difference in activation in brain
regions that differed between the Neutral vs the Cocaine-cues
video (with placebo or with MP) and the changes in cocaine
craving. For this purpose we obtained the metabolic values in
circular regions of interest (diameter 7 voxels) placed on the center
of the clusters identified by SPM as differing between the Neutral
and the Cocaine-cues videos. We also performed voxel-wise
correlations between the changes in metabolism (neutral vs
Cocaine-cue) and changes in measures of craving and significance
was set at p,0.005 (uncorrected .100 voxels).
Supporting Information
Figure S1 SPM results for the voxel-wise correlation between
changes in metabolism and changes in self-reports of cocaine
craving (Neutral - Cocaine-cues) for the Methylphenidate
condition for a threshold of significance of p,0.05 uncorrected,
cluster size .200 voxels.
Found at: doi:10.1371/journal.pone.0011509.s001 (2.06 MB TIF)
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